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DOWNREGULATION OF FABP4 PROMOTES OSTEOCLAST FORMATION AND
FUNCTION BY ACTING PPAR-g SIGNALING
Yuting Wang, Yonghui Dong, Chao Song, Weiwei Lu, Kun Chen, Hui Liu,
Xuejun Zhang, Anmin Chen
Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong
University of Science and Technology, China
Background: Fatty acid-binding proteins (FABPs) are critical mediators of meta-
bolism and inflammatory processes both locally and systemically, and has been
proved not only be responsible for the formation of mature adipocytes but also
function as the key modulator in osteoblast formation and osteogenesis. It has
been reported that FABP4 had the capacity to enhance the adipogenesis of BMSCs,
and broke the balance between adipocyte and osteoblast differentiation in bone
marrow system. Researches on the side effects of Methotrexate chemotherapy,
such as osteopenia, osteoporosis and fractures, also show that the gene expression
of FABP4 is up-regulated in the stromal population. However, the relationship be-
tween FABP4 and osteoclast formation remains poorly understood, our research is
aimed to find out what role FABP4 takes in osteoclast formation and bone
resorption.
Subjects and Methods: BMM was collected from 6-week-old C57/BL6 mice, and
induced to the osteoclast in the presence of M-CSF and RANKL for 6 days, BMS
were used as the inhibitor of FABP4, protein expression of RAP, CK, MMP9, NFATC1,
c-fos and PPAR-g were evaluated on day 1, day 3, and day 5 by Western Blot, RT-
PCR gene expression analysis on TRAP, CK, and MMP9 were also performed on day
2. On day 6, the cells were fixed and stained for TRAP assay in both BMS and
BMS+GW9962 groups. And Pit formation assays on BMS group were also performed
on day 6.
Results: In Western Blot, BMS suppresses expression of FABP4. However, the
expression of TRAP, CK, MMP9, NFATC1, c-fos and PPAR-g were increased on day
1, day 3, and day. RT-PCR gene expression analyses showed TRAP, CK, and MMP9
to be up-regulated on day 2. TRAP assays and Pit formation assays also showed
that osteoclast formation and function is promoted under BMS treatment. We
also investigated whether FABP4 is correlated with PPAR-g and have an effect
on osteoclast genesis by TRAP assays and Western Blot. In Western Blot, the pro-
tein expression of PPARg is decreased. The TRAP assays result also shows that
the formation of osteoclast is suppressed with the additional presence of
GW9662 (a PPARg inhibitor).
Discussion and Conclusion: Our research shows that block FABP4 have a positive
impact on osteoclast formation, which is produced by acting PPAR-gsignaling.
These phenomenon highlighting that the overexpression FABP4 can be a new po-
tential target for treating osteopenia related dysfunction.
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CXCL12/CXCR4 AXIS PROMOTES VASCULOGENIC MIMICRY VIA PI3K/AKT
SIGNALING IN OSTEOSARCOMA
Liang Qin, An-min Chen, Feng-jing Guo, Qing Yang, Hui Liao
Tongji Hospital, Tongji Medical College, Huazhong University of Science and
Technology, China
Background: The term vasculogenic mimicry (VM) refers to the unique capability
of aggressive tumor cells to mimic the pattern of embryonic vasculogenic net-
works. Although VM has been shown to occur in osteosarcoma, a degree of which
correlates with a poor clinical outcome, the precise molecular events underlying
the process of VM in osteosarcoma have not been well defined. In this study, we
explored osteosarcoma as a VM model in order to investigate the role of
CXCL12/CXCR4 axis in VM formation.
Subjects and Methods: The effect of SDF-1 with different concentrations
(10,100mmol/L) and different action times (1 to 6 days) on the growth of osteosar-
coma cell line MG-63 was detected by Cell Counting Kit-8(CCK-8) analysis. The VM
abilities of osteosarcoma cells were detected by a well-established in vitro 3D
model of VM formation. The expression of CXCR4, Akt and p-Akt were detected
by RT-PCR or Western blot.
Results: Osteosarcoma MG63 cells could form patterned matrix VM or tubular VM in
3D cultures in vitro and CXCL12 effectively promoted the formation of VM struc-
tures. Inhibition of CXCR4 function by an antagonist AMD3100 blocked CXCL12-
induced VM formations of MG63 cells. Furthermore, CXCL12 increased phosphory-
lation of Akt. Additionally, blocking PI3K/Akt Pathway using a PI3K inhibitor
LY294002 decreased CXCL12-induced VM formations of MG63 cells.
Discussion and Conclusion: The results of this study indicate that CXCL12/CXCR4
axis plays an important role in osteosarcoma VM formation more through the PI3K/AKT signaling. Our findings also demonstrate a novel cogitation in inhibition of os-
teosarcoma angiogenesis and metastasis.
http://dx.doi.org/10.1016/j.jot.2016.06.170Session: Disease & Treatment e Skeletal Growth & Development
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ALENDRONATE-MODIFIED LIPOSOME FOR BONE TARGETING GENE DELIVERY
REGULATING MESENCHYMAL STEM CELL MIGRATION
Chuping Zheng, Haobo Pan, Xiaoli Zhao
Shenzhen Institutes of Advanced Technology, Chinese Academy of Science, China
Introduction: Aging is usually related to an increase in metabolic skeletal disorders
such as osteoporosis and bone metastases, accompanied with the decrease in
mesenchymal stem cells (MSCs) number.1 For bone regeneration, directing MSCs
toward the bone surface is a key step for further osteogenic differentiation.2 Stro-
mal cell-derived factor-1 (SDF-1) has been reported with the effect in inducing MSC
migration.3 Construction of the bone targeted gene delivery system would be a
promising way to locally express SDF-1 on bone surface for attracting MSC migra-
tion and differentiation. This study aimed to develop bone targeting liposome by
alendronate (Aln) modification for modulating MSC migration.
Subjects and Methods: Aln was conjugated to DSPE-PEG2000-COOH via carbodii-
mide chemistry through the reaction between carboxyl and amino. Aln-liposome
was prepared using the thin-film hydration method with the component of DOTAP,
DOPE, cholesterol, DSPE-PEG2000 and DSPE-PEG2000-Aln. The morphology of lipo-
somes was observed by TEM. The transfection efficiency was examined by trans-
fection of COS-1 cell with GFP reporter gene and luciferase gene. Bone target
ability was examined using fluorescence absorption test. In vitro cytotoxicity of
Aln-liposome was evaluated by CCK-8 assay. Then Aln-liposome was applied to
SDF-1 gene delivery to MC3T3 osteoblast cells for MSC migration. The expressed
SDF-1 mRNA and protein in MC3T3 cells after transfection were examined by RT-
PCR and Western blot.
Results: Bone targeting Aln-liposome was prepared by conjugating liposome with
alendronate. The average diameter of liposome was around 104 nm measured by
a dynamic light scattering detector. TEM image showed the sphere morphology
of Aln-liposome. The critical DNA complex ratio examined by gel retardation was
1:1 (N/P). The transfection efficiency of Aln-liposome was even higher than that
of Lipofectamine 2000 shown by luciferase and GFP reporter gene expression in
COS-1 cell. The cytotoxicity of Aln-liposome investigated by cck-8 assay was lower
than that of Lipofectamine 2000 in COS-1 cells. More than 90% of cell viability
could be observed in the cells when the concentration of liposomes reached
50 mg/mL. Aln-liposome showed the bone targeting ability in vitro. The binded li-
posomes increased from 13.7% to 61.4% after modification with alendronate by
examining the changes in fluorescence of NBD-labeled liposome after mixed with
hydroxyapatite. Aln-liposome was then applied to deliver SDF-1 gene to MC3T3
osteoblast cells, and its expression was confirmed by PCR and western blot. The
expressed SDF-1 showed the effect in attracting MSC migration in transwell
culture.
Discussion and Conclusion: Alendronate modified liposome showed the bone tar-
geting ability and high gene transfection efficiency. By delivery SDF-1 gene, this
system could attract MSC migration. This study provides a novel potential tech-
nique for bone regeneration.
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CHEMICAL-DRIVEN LINEAGE CONVERSION FROM MOUSE FIBROBLASTS TO
CARTILAGE
Yishan Chen
School of Medicine, Zhejiang University, China
Objective: To overcome the cell source limitation and scar tissue accumulation in
cartilage repair, lineage conversion with transcription factors from fibroblasts to
chondrocytes provides a promising approach. However, genetic manipulation rai-
ses safety concerns in clinical application, while small molecule compounds are
more cost-effective and easily-standardized. This study aims to illustrate the
achievement of a gene-free conversion from mouse fibroblasts to cartilage tissue
by chemical cocktails.
Methods and Materials: In this study we showed that mouse embryonic fibroblasts
(MEFs) could be successfully induced into chondrocytes by a two-stage protocol.
Chemical cocktails and hypoxia atmosphere were essential in the first 6 days, to
Poster Presentation Abstracts 129drive MEFs to an intermediate stage. Then chondrogenic growth factors were used
to complete the induction by 2D/3D culture. Cells of each stage were character-
ized by immunofluorenscence and single cell sequencing. A col2-pd2EGFP reporter
system played a role in the following high-throughput screening for efficiency
optimization.
Results: Col2+ chondrocyte-like clusters could be visualized after chemical induc-
tion by 2D/3D culture. Consequently, 3D culture (micromass and suspension cul-
ture) with TFGb3 promoted the chondrogenesis of chemical-induced MEFs
compared to monolayer culture, resulting in a cartilage-like particle. For the
whole chemical lineage conversion, the first stage was essential, during which fi-
broblasts were driven into an intermediate stage with pluripotent colonies and
heterogenous cell subpopulation. With the help of col2-pd2EGFP screening system,
we discovered that adding other 2 small molecule compounds during the first stage
significantly increased the fibroblast-to-chondrocyte conversion efficiency.
Conclusion: This study demonstrates the possibility of chemical conversion from
mouse fibroblasts to cartilage-like tissue without genetic manipulation. This proof
of concept study lays a foundation for high-throughput screening of chondrogenic
inducers and in vivo chemical conversion in clinical cartilage repair.
http://dx.doi.org/10.1016/j.jot.2016.06.172Session: Disease & Treatment e Osteoarthritis
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DIFFERENT EFFECTS OF PREDNISONE TREATMENT FOR 30 DAYS AND 90 DAYS
ON BONE METABOLISM IN COLLAGEN-INDUCED ARTHRITIS (CIA) RATS
Xuemei Zhang a, Jiaqi Lu a, Xuna Wu a, Xinle Zhang a, Liyi Zou a, Liao Cui a,b,
Bilian Xu a,b
aDepartment of Pharmacology, Guangdong Medical University, Zhanjiang,
Guangdong, China
bGuangdong Key Laboratory for Research and Development of Natural Drugs,
Guangdong Medical University, Zhanjiang, Guangdong, China
Background: Glucocorticoids (GCs) are often prescribed to treat RA for a long
time, but there is still controversy in the administration of GCs, mainly because
of the adverse reactions, such as osteoporosis. How to control the dosage and
duration of GCs treatment is the problem we need to solve. The aim of this
study was to investigate the different effects of prednisone treatment for 30
days and 90 days on bone metabolism in collagen-induced arthritis (CIA) rats
and hope to provide a reasonably clinical application of glucocorticoids for
the treatment of RA.
Subjects and Methods: Fifty 8-week-old female Lewis rats were randomly
divided into 2 groups, normal group with 12 rats and the remaining 38 rats
were used to establish the CIA model. Four weeks after immunization, 24 rats
which were successfully infected with arthritis (arthritis index 4) were
randomly divided into CIA treated with vehicle group and CIA treated with pred-
nisone group. 6 rats were killed in each group on the 30d and 90d respectively.
Bone histomorphometry, bone mineral density (BMD), micro-computer tomogra-
phy (micro-CT), biomechanical test and enzyme-linked immunosorbent assay
were performed.
Results: Compared with normal rats, in fourth lumbar vertebrae (LV4), percent
trabecular area (%Tb.Ar) and trabecular number (Tb.N) were significantly
decreased, while trabecular separation (Tb.Sp), percent osteoclast surface perim-
eter (%Oc.S.Pm), percent labeled perimeter (%L.Pm) and bone turnover rate (BFR/
BV) were significantly increased in CIA rats. Poor trabecular structure and less
trabecular bone of femur were seen in CIA rats by micro-CT scanning. BMD and
biomechanical properties of femur were significantly decreased in CIA rats. Serum
level of PINP, sRANKL and CTX-I were increased in CIA rats treated with vehicle for
90 days. Compared with CIA rats, %Tb.Ar and Tb.N of LV4 in CIA rats treated with
prednisone for 30 days were increased, but there was no significant change in CIA
rats treated with prednisone for 90 days. Prednisone treatment for 30 days
increased bone volume and improved microarchitecture of distal femur. Predni-
sone treatment for 90 days increased bone volume, but there was no significant
improvement in microarchitecture of femur. In additional, serum levels of OPG
and PINP were decreased in CIA rats treated with vehicle for 90 days. There was
no significant change in biomechanical properties of femur between CIA rats
treated with vehicle and prednisone.
Discussion and Conclusion: High bone turnover osteoporosis could be shown in CIA
rats, manifested by decrease of trabecular bone mass, structural degradation.
Reduction of bone mineral density and biomechanical weak-ness. Prednisone
treatment for 30 days decelerated the degeneration of trabecular bone in CIA
rats, but did not improve bone mineral density and bone biomechanics. In addi-
tional, the protective effect of prednisone treatment for 30 days on bone in CIA
rats was better than that of 90 days. Decrease of bone mass was not directly
seen in CIA rats treated with prednisone for 90 days, but there was a negative ef-
fect on bone metabolism.
http://dx.doi.org/10.1016/j.jot.2016.06.173Session: Biomechanics e Cell & Molecular Biomechanics
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PROMOTING EFFECT OF STRONTIUM ON THE DIVISION OF STEM CELLS IN BONE
FORMATION
Yanqun Li, Haobo Pan, William Weijia Lu, Xiaoli Zhao
Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, China
Introduction: Strontium ranelate has been shown to reduce the risk of verte-
bral fracture in postmenopausal women [1]. The beneficial effects of stron-
tium on promoting bone formation are closely related to its capability to
increase the osteogenic differentiation of mesenchymal stem cells [2,3]. How-
ever, the molecular mechanisms are still not fully understood. The aim of this
study is to investigate the mechanism underlying the promoted effect of stron-
tium in inducing osteogenic differentiation of mesenchymal stem cells in early
stage.
Subjects and Methods: Eight-week-old male C57BL/6 mice were randomly divided
into experiment group and control group. Sr was daily oral administration in exper-
imental group and vehicle (0.9% saline) in control group respectively for 4 weeks.
The effect of Sr on trabecular bone microstructure was analyzed by micro-CT on
proximal tibia. Human fetal BMSC (hfBMSC) which characterized by multi-differen-
tiation were cultured in control group (control), osteogenic group (Osteo) and Sr
promoted osteogenic group (Osteo+Sr). The osteogenic and asymmetric differenti-
ation related genes were analyzed by quantitative PCR. The protein level of asym-
metric differentiation related gene was detected by western blot. The effect of Sr
on trabecular bone microstructure was analyzed by micro-CT on proximal tibia.
Results: The microstructure analysis of trabecular bone in proximal tibia showed
that Sr significantly increased trabecular number and connectivity density. In the
first week of hfBMSC culture, the related osteoblastic genes Osterix, osteopontin
and BSP were significantly enhanced in osteogenic induced group from day3.
With the addition of Sr, these genes were expressed at even higher levels. The
gene Numb associated with asymmetric differentiation was promoted in Osteo+Sr
groups in day3. At the same time in the immunofluorescence images, the osteo-
genic differentiation could be observed in Osteo and Osteo+Sr group. Oster+Sr
showed higher proportion of the osterix positive cells. It should be noted that
the divided cells showed one osterix positive cell and one oct-4 positive cell. In
western blot, Sr stimulated the expression of Numb in the early stage of osteogenic
differentiation.
Discussion and Conclusion: During the osteogenic differentiation of hfBMSC, Sr is
related to the enhanced effect in asymmetric division of stem cell in the early
stage.
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DISRUPTION OF GLUCOCORTICOID SIGNAL IN OSTEOBLASTS AND OSTEOCYTES
ATTENUATES HINDLIMB UNLOADING-INDUCED BONE LOSS IN MICE
Jiancheng Yang a, Wenbin Li a, Yanru Xue a, Hong Zhou b, Huiyun Xu a,
Peng Shang a, Jingbao Li a
aKey Laboratory for Space Biosciences and Biotechnology, Institute of Special
Environment Biophysics, School of Life Sciences, Northwestern Polytechnical
University, Xi’an, Shaanxi, China
bBone Research Program, The Australian and New Zealand Army Corps (ANZAC)
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Objective: Bone loss induced by weightlessness has been a hot issue in space
physiology, but the accurate mechanism is still not clear. At present, the lack
of mechanical stimulation is considered to be an important factor for bone
loss under weightlessness environment. However, besides mechanical unload-
ing, it is inevitable that the stress in weightlessness environment induced in-
crease of endogenous glucocorticoid (GC) levels. High levels of GCs have been
established as risk factors for low bone mineral density and an increase in frac-
ture risk. A recent progress showed that osteoblast-targeted disruption of intra-
cellular GC signaling can prevent transgenic mice in chronic stress from bone
loss, which indicated GC play an important role in stress-induced bone loss
and a possible role in weightlessness induced bone loss. Therefore it is the
aim of the present study to explore the role of GC in unloading-induced bone
loss of mice.
